Literature DB >> 5786759

Abuse of methylamphetamine.

D Hawks, M Mitcheson, A Ogborne, G Edwards.   

Abstract

Seventy-four regular users of methylamphetamine injections were interviewed in four settings by use of a relatively structured standardized questionary. All but two had injected methylamphetamine within the previous 48 hours and had on average been using methylamphetamine continuously for 19 months.Significant features found in those interviewed were British nationality, single status, under 25 years of age, and a history of parental separation, absence, or bereavement. Educational standards were poor and a history of consistent truancy from secondary school was frequently reported.Comparison of their best and present occupations showed that downward drift had occurred. Forty-one per cent. of the sample had some definite or tentative evidence of neurotic disturbance in childhood. Twenty-three per cent. had been sentenced to detention centre, approved school, or Borstal training, and 20% had been sentenced to prison. Sixty-five per cent. had been charged with offences of one sort and 24% had been convicted of both drug and non-drug offences.A significant number had been heavy drinkers in the past, while most had been, and in many cases still were, multiple-drug users who had first started to use drugs between the ages of 16 and 20 years. They tended to have obtained methylamphetamine initially from people they knew or from sellers. While the majority were currently getting methylamphetamine from doctors, the fact that 40% gave non-medical agents as their major source of drugs suggests that a significant number were supplementing their supplies from illicit sources. More than one-half were rated as being continually involved in the "drug scene."Most of those interviewed accepted frequent psychotic episodes as a side-effect of their use of methylamphetamine. Malnutrition, weight loss, and sleep disturbance were frequent.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5786759      PMCID: PMC1983531          DOI: 10.1136/bmj.2.5659.715

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

1.  DRUG ADDICTION. ADOLESCENT DRUG TAKING.

Authors:  P H CONNELL
Journal:  Proc R Soc Med       Date:  1965-06

2.  Psychoses due to amphetamine consumption.

Authors:  P BEAMISH; L G KILOH
Journal:  J Ment Sci       Date:  1960-01

3.  Habituation and addiction to amphetamines.

Authors:  L G KILOH; S BRANDON
Journal:  Br Med J       Date:  1962-07-07

4.  Observations on Benzedrine.

Authors:  E Guttmann; W Sargant
Journal:  Br Med J       Date:  1937-05-15

5.  A methylamphetamine epidemic?

Authors:  I P James
Journal:  Lancet       Date:  1968-04-27       Impact factor: 79.321

6.  Abuse of methylamphetamine.

Authors:  M M Glatt
Journal:  Lancet       Date:  1968-07-27       Impact factor: 79.321

7.  Delinquency and the amphetamines.

Authors:  P D Scott; D R Willcox
Journal:  Br J Psychiatry       Date:  1965-09       Impact factor: 9.319

8.  Amphetamine abuse. Pattern and effects of high doses taken intravenously.

Authors:  J C Kramer; V S Fischman; D C Littlefield
Journal:  JAMA       Date:  1967-07-31       Impact factor: 56.272

  8 in total
  15 in total

1.  Amphetamines.

Authors: 
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

Review 2.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Neurol Clin       Date:  2011-06-24       Impact factor: 3.806

3.  Rigidity, hyperpyrexia and coma following fluphenazine enanthate.

Authors:  H Y Meltzer
Journal:  Psychopharmacologia       Date:  1973

4.  Drug-taking in delinquent boys.

Authors:  P J Noble
Journal:  Br Med J       Date:  1970-01-10

5.  Drug taking in adolescent girls: factors associated with the progression to narcotic use.

Authors:  P Noble; G G Barnes
Journal:  Br Med J       Date:  1971-06-12

6.  Misuse of temazepam.

Authors:  M Farrell; J Strang
Journal:  BMJ       Date:  1988-11-26

7.  Hepatitis associated with illicit use of intravenous methamphetamine.

Authors:  L E Davis; G Kalousek; E Rubenstein
Journal:  Public Health Rep       Date:  1970-09       Impact factor: 2.792

8.  Methamphetamine induces striatal neurokinin-1 receptor endocytosis primarily in somatostatin/NPY/NOS interneurons and the role of dopamine receptors in mice.

Authors:  Jing Wang; Jesus A Angulo
Journal:  Synapse       Date:  2010-09-24       Impact factor: 2.562

9.  Clinical features of methamphetamine-induced paranoia and preliminary genetic association with DBH-1021C→T in a Thai treatment cohort.

Authors:  Rasmon Kalayasiri; Viroj Verachai; Joel Gelernter; Apiwat Mutirangura; Robert T Malison
Journal:  Addiction       Date:  2014-03-17       Impact factor: 6.526

Review 10.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Psychiatr Clin North Am       Date:  2013-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.